Adam Boehler - May 29, 2024 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role: Director
Signature: /s/ Anita Beth Adams, as attorney-in-fact
Stock symbol: PRVA
Transactions as of: May 29, 2024
Transactions value $: $87,549
Form type: 4
Date filed: 5/31/2024, 04:13 PM
Previous filing: May 29, 2024
Next filing: Jun 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRVA	Common Stock, $0.01 par value per share	Purchase	$87.5K	+5.31K	+0.09%	$16.50	5.77M	May 29, 2024	See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.48 to $16.50 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Content

Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.48 to $16.50 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.